64 related articles for article (PubMed ID: 23305591)
1. MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas.
Lubezky N; Loewenstein S; Ben-Haim M; Brazowski E; Marmor S; Pasmanik-Chor M; Oron-Karni V; Rechavi G; Klausner JM; Lahat G
Surgery; 2013 May; 153(5):663-72. PubMed ID: 23305591
[TBL] [Abstract][Full Text] [Related]
2. Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms.
Agostini A; Piro G; Inzani F; Quero G; Esposito A; Caggiano A; Priori L; Larghi A; Alfieri S; Casolino R; Scaglione G; Tondolo V; Cammarota G; Ianiro G; Corbo V; Biankin AV; Tortora G; Carbone C
Nat Commun; 2024 Mar; 15(1):2764. PubMed ID: 38553466
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.
Iacobuzio-Donahue CA; Maitra A; Shen-Ong GL; van Heek T; Ashfaq R; Meyer R; Walter K; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
Am J Pathol; 2002 Apr; 160(4):1239-49. PubMed ID: 11943709
[TBL] [Abstract][Full Text] [Related]
4. An integrative analysis of microRNA and mRNA expression--a case study.
Qin LX
Cancer Inform; 2008; 6():369-79. PubMed ID: 19259417
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreas.
Permuth-Wey J; Chen YA; Fisher K; McCarthy S; Qu X; Lloyd MC; Kasprzak A; Fournier M; Williams VL; Ghia KM; Yoder SJ; Hall L; Georgeades C; Olaoye F; Husain K; Springett GM; Chen DT; Yeatman T; Centeno BA; Klapman J; Coppola D; Malafa M
PLoS One; 2015; 10(1):e0116869. PubMed ID: 25607660
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic Cancer: Genetic Conditions and Epigenetic Alterations.
Montalvo-Javé EE; Nuño-Lámbarri N; López-Sánchez GN; Ayala-Moreno EA; Gutierrez-Reyes G; Beane J; Pawlik TM
J Gastrointest Surg; 2023 May; 27(5):1001-1010. PubMed ID: 36749558
[TBL] [Abstract][Full Text] [Related]
7. Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN).
Zhang C; Al-Shaheri FN; Alhamdani MSS; Bauer AS; Hoheisel JD; Schenk M; Hinz U; Goedecke P; Al-Halabi K; Büchler MW; Giese NA; Hackert T; Roth S
Clin Cancer Res; 2023 Apr; 29(8):1535-1545. PubMed ID: 36516200
[TBL] [Abstract][Full Text] [Related]
8. A pilot study to troubleshoot quality control metrics when assessing circulating miRNA expression data reproducibility across study sites.
Permuth JB; Mesa T; Williams SL; Cardentey Y; Zhang D; Pawlak EA; Li J; Cameron ME; Ali KN; Jeong D; Yoder SJ; Chen DT; Trevino JG; Merchant N; Malafa M
Cancer Biomark; 2022; 33(4):467-478. PubMed ID: 35491771
[TBL] [Abstract][Full Text] [Related]
9. MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing.
Kuratomi N; Takano S; Fukasawa M; Maekawa S; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Kawakami S; Hayakawa H; Takada H; Nakakuki N; Kato R; Yamaguchi T; Nakayama Y; Kawaida H; Kono H; Inoue T; Kondo T; Ichikawa D; Enomoto N
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809988
[TBL] [Abstract][Full Text] [Related]
10. Exosomal miRNA signatures of pancreatic lesions.
Vicentini C; Calore F; Nigita G; Fadda P; Simbolo M; Sperandio N; Luchini C; Lawlor RT; Croce CM; Corbo V; Fassan M; Scarpa A
BMC Gastroenterol; 2020 May; 20(1):137. PubMed ID: 32375666
[TBL] [Abstract][Full Text] [Related]
11. Micro-RNA Expression Patterns Predict Metastatic Spread in Solid Pseudopapillary Neoplasms of the Pancreas.
Cohen SJ; Papoulas M; Graubardt N; Ovdat E; Loewenstein S; Kania-Almog J; Pasmanik-Chor M; Brazowski E; Cagnano E; Nachmany I; Lahat G; Klausner JM; Lubezky N
Front Oncol; 2020; 10():328. PubMed ID: 32232006
[TBL] [Abstract][Full Text] [Related]
12. Molecular Diagnosis of Cystic Neoplasms of the Pancreas: a Review.
Chen JC; Beal EW; Pawlik TM; Cloyd J; Dillhoff ME
J Gastrointest Surg; 2020 May; 24(5):1201-1214. PubMed ID: 32128679
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-21 inhibits the malignant phenotype of pancreatic cancer cells by targeting VHL.
Sun J; Jiang Z; Li Y; Wang K; Chen X; Liu G
Onco Targets Ther; 2019; 12():7215-7226. PubMed ID: 31564905
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA profiling of pancreatic ductal adenocarcinoma (PDAC) reveals signature expression related to lymph node metastasis.
Lemberger M; Loewenstein S; Lubezky N; Nizri E; Pasmanik-Chor M; Barazovsky E; Klausner JM; Lahat G
Oncotarget; 2019 Apr; 10(27):2644-2656. PubMed ID: 31080555
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in pancreatic cancer diagnosis and therapy.
Słotwiński R; Lech G; Słotwińska SM
Cent Eur J Immunol; 2018; 43(3):314-324. PubMed ID: 30588176
[TBL] [Abstract][Full Text] [Related]
16. Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas.
Tulla KA; Maker AV
Langenbecks Arch Surg; 2018 Mar; 403(2):151-194. PubMed ID: 29218397
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression levels as diagnostic biomarkers for intraductal papillary mucinous neoplasm.
Wang L; Zheng J; Sun C; Wang L; Jin G; Xin L; Jin Z; Wang D; Li Z
Oncotarget; 2017 Aug; 8(35):58765-58770. PubMed ID: 28938594
[TBL] [Abstract][Full Text] [Related]
18. Linc-ing Circulating Long Non-coding RNAs to the Diagnosis and Malignant Prediction of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Permuth JB; Chen DT; Yoder SJ; Li J; Smith AT; Choi JW; Kim J; Balagurunathan Y; Jiang K; Coppola D; Centeno BA; Klapman J; Hodul P; Karreth FA; Trevino JG; Merchant N; Magliocco A; Malafa MP; Gillies R
Sci Rep; 2017 Sep; 7(1):10484. PubMed ID: 28874676
[TBL] [Abstract][Full Text] [Related]
19. Incidents and adverse events of endoscopic ultrasound-guided fine-needle aspiration for pancreatic cystic lesions.
Du C; Chai NL; Linghu EQ; Li HK; Sun YF; Xu W; Wang XD; Tang P; Yang J
World J Gastroenterol; 2017 Aug; 23(30):5610-5618. PubMed ID: 28852320
[TBL] [Abstract][Full Text] [Related]
20. Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Al Efishat MA; Attiyeh MA; Eaton AA; Gönen M; Prosser D; Lokshin AE; Castillo CF; Lillemoe KD; Ferrone CR; Pergolini I; Mino-Kenudson M; Rezaee N; Dal Molin M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; Kingham TP; DeMatteo RP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Aug; 268(2):340-347. PubMed ID: 28700444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
